← All cap tiers
Cap tier

Small Cap

Every analyzed stock in Small Cap — 1,523 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Most overvalued Most shorted Buyers' strike Largest
OLMA
Olema Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$7.82
Model IV—
P/IV—
Limited data — see page
OLN
OLIN Corp
Deeply undervalued
Basic Materials
Price$14.89
Model IV$55.68
P/IV0.30
Discount 73% Return to IV: +273.9%
Market implies -23.3%/yr vs model +1.5% · below model
OLP
ONE LIBERTY PROPERTIES INC
Overvalued
Financial Services
Price$21.96
Model IV$17.61
P/IV1.34
Premium +25% Return to IV: -19.8%
OLPX
OLAPLEX HOLDINGS, INC.
Deeply overvalued
Consumer Defensive
Price$2.07
Model IV$1.21
P/IV1.69
Premium +71% Return to IV: -41.6%
Market implies +8.4%/yr vs model +2.9% · above model
OMDA
Omada Health, Inc.
Deeply undervalued
Healthcare
Price$21.55
Model IV$54.67
P/IV0.33
Discount 61% Return to IV: +153.7%
Market implies -16.6%/yr vs model +45.6% · below model
OMER
OMEROS CORP
Valuation N/A
Healthcare
Price$19.83
Model IV—
P/IV—
Limited data — see page
ONT
Onterris, Inc.
Undervalued
Industrials
Price$13.81
Model IV$19.06
P/IV0.84
Discount 28% Return to IV: +38.0%
Market implies +2.0%/yr vs model +9.5% · below model
OOMA
OOMA INC
Deeply overvalued
Technology
Price$20.04
Model IV$4.67
P/IV4.72
Premium +329% Return to IV: -76.7%
Market implies +28.2%/yr vs model +11.2% · above model
OPFI
OppFi Inc.
Deeply undervalued
Financial Services
Price$5.93
Model IV$34.20
P/IV0.18
Discount 83% Return to IV: +476.7%
Market implies -21.8%/yr vs model +8.5% · below model
OPK
OPKO HEALTH, INC.
Deeply overvalued
Healthcare
Price$1.38
Model IV$0.43
P/IV3.41
Premium +223% Return to IV: -69.0%
Market implies +14.1%/yr vs model +2.0% · above model
OPRA
Opera Ltd
Fairly valued
Technology
Price$17.58
Model IV$19.36
P/IV0.92
Discount 9% Return to IV: +10.1%
Market implies +10.0%/yr vs model +15.9% · below model
OPRT
Oportun Financial Corp
Fairly valued
Financial Services
Price$8.92
Model IV$8.87
P/IV0.96
Premium +1% Return to IV: -0.5%
Market implies +6.3%/yr vs model +9.0% · in line
OPTT
Ocean Power Technologies, Inc.
Deeply overvalued
Utilities
Price$0.85
Model IV$0.64
P/IV4.25
Premium +32% Return to IV: -24.3%
OPTU
Optimum Communications, Inc.
Valuation N/A
Communication Services
Price$0.93
Model IV—
P/IV—
Market implies -50.0%/yr vs model +0.9% · below model
OPTX
SYNTEC OPTICS HOLDINGS, INC.
Valuation N/A
Technology
Price$8.09
Model IV—
P/IV—
Market implies +33.5%/yr
OPY
OPPENHEIMER HOLDINGS INC
Deeply undervalued
Financial Services
Price$113.94
Model IV$218.33
P/IV0.42
Discount 48% Return to IV: +91.6%
Market implies -4.2%/yr vs model +7.0% · below model
ORBS
Eightco Holdings Inc.
Deeply overvalued
Financial Services
Price$0.84
Model IV$0.62
P/IV1.49
Premium +35% Return to IV: -25.8%
Market implies +10.9%/yr vs model +43.1% · below model
ORC
Orchid Island Capital, Inc.
Valuation N/A
Financial Services
Price$5.08
Model IV—
P/IV—
Limited data — see page
ORGO
Organogenesis Holdings Inc.
Deeply undervalued
Healthcare
Price$1.29
Model IV$3.46
P/IV0.74
Discount 63% Return to IV: +168.2%
Market implies -15.2%/yr vs model +4.8% · below model
ORIC
Oric Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$11.99
Model IV—
P/IV—
Limited data — see page
ORN
Orion Group Holdings Inc
Deeply undervalued
Industrials
Price$9.15
Model IV$13.60
P/IV0.66
Discount 33% Return to IV: +48.6%
Market implies -3.5%/yr vs model +9.1% · below model
ORRF
ORRSTOWN FINANCIAL SERVICES INC
Fairly valued
Financial Services
Price$40.90
Model IV$38.63
P/IV1.06
Premium +6% Return to IV: -5.5%
OSBC
OLD SECOND BANCORP INC
Fairly valued
Financial Services
Price$24.61
Model IV$23.19
P/IV0.92
Premium +6% Return to IV: -5.8%
OSPN
OneSpan Inc.
Deeply overvalued
Technology
Price$18.22
Model IV$13.42
P/IV1.08
Premium +36% Return to IV: -26.3%
Market implies +8.2%/yr vs model +5.8% · in line
OVID
Ovid Therapeutics Inc.
Valuation N/A
Healthcare
Price$2.46
Model IV—
P/IV—
Market implies +74.0%/yr vs model +2.0% · above model
OXM
OXFORD INDUSTRIES INC
Deeply undervalued
Consumer Cyclical
Price$25.38
Model IV$100.37
P/IV0.26
Discount 75% Return to IV: +295.5%
Market implies -16.0%/yr vs model +7.6% · below model
OZKAP
Bank OZK
Valuation N/A
Unknown
Price$14.95
Model IV—
P/IV—
Limited data — see page
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Valuation N/A
Healthcare
Price$2.33
Model IV—
P/IV—
Market implies +50.2%/yr vs model +5.2% · above model
PACK
Ranpak Holdings Corp.
Valuation N/A
Basic Materials
Price$3.71
Model IV—
P/IV—
Market implies +16.7%/yr vs model +0.0% · above model
PAHC
PHIBRO ANIMAL HEALTH CORP
Deeply overvalued
Healthcare
Price$38.30
Model IV$20.32
P/IV1.52
Premium +88% Return to IV: -46.9%
Market implies +16.5%/yr vs model +11.2% · above model
PALI
PALISADE BIO, INC.
Valuation N/A
Healthcare
Price$1.54
Model IV—
P/IV—
Market implies +85.8%/yr vs model +15.0% · above model
PAMT
PAMT CORP
Fairly valued
Industrials
Price$12.78
Model IV$12.80
P/IV3.46
Discount 0% Return to IV: +0.1%
Market implies +1.2%/yr vs model +2.0% · in line
PAR
PAR TECHNOLOGY CORP
Undervalued
Technology
Price$15.51
Model IV$18.95
P/IV0.81
Discount 18% Return to IV: +22.2%
Market implies -3.6%/yr vs model +12.7% · below model
PAX
Patria Investments Ltd
Fairly valued
Financial Services
Price$11.67
Model IV$13.68
P/IV0.75
Discount 15% Return to IV: +17.2%
Market implies +4.7%/yr vs model +9.9% · below model
PAYS
Paysign, Inc.
Fairly valued
Technology
Price$15.37
Model IV$17.90
P/IV0.41
Discount 14% Return to IV: +16.5%
Market implies +15.1%/yr vs model +24.0% · below model
PBFS
Pioneer Bancorp, Inc./MD
Deeply overvalued
Financial Services
Price$17.40
Model IV$10.07
P/IV1.48
Premium +73% Return to IV: -42.1%
PBT
PERMIAN BASIN ROYALTY TRUST
Deeply overvalued
Financial Services
Price$34.86
Model IV$10.95
P/IV3.03
Premium +218% Return to IV: -68.6%
PBYI
PUMA BIOTECHNOLOGY, INC.
Fairly valued
Healthcare
Price$10.29
Model IV$9.98
P/IV0.72
Premium +3% Return to IV: -3.0%
Market implies +2.1%/yr vs model +3.0% · in line
PCB
PCB BANCORP
Fairly valued
Financial Services
Price$27.73
Model IV$27.20
P/IV0.90
Premium +2% Return to IV: -1.9%
PCRX
Pacira BioSciences, Inc.
Undervalued
Healthcare
Price$36.31
Model IV$45.52
P/IV0.54
Discount 20% Return to IV: +25.4%
Market implies +3.5%/yr vs model +9.3% · below model
PCTTU
PureCycle Technologies, Inc.
Valuation N/A
Basic Materials
Price$4.37
Model IV—
P/IV—
Market implies +57.9%/yr vs model +5.0% · above model
PD
PagerDuty, Inc.
Fairly valued
Technology
Price$16.16
Model IV$15.31
P/IV0.97
Premium +6% Return to IV: -5.3%
Market implies -1.1%/yr vs model +15.0% · below model
PDLB
Ponce Financial Group, Inc.
Deeply overvalued
Financial Services
Price$20.05
Model IV$13.97
P/IV1.35
Premium +44% Return to IV: -30.3%
PDM
Piedmont Realty Trust, Inc.
Deeply overvalued
Real Estate
Price$9.03
Model IV$2.55
P/IV3.26
Premium +254% Return to IV: -71.8%
PDS
PRECISION DRILLING Corp
Fairly valued
Energy
Price$84.14
Model IV$88.48
P/IV0.93
Discount 5% Return to IV: +5.2%
Market implies +3.9%/yr vs model +6.9% · in line
PEB
Pebblebrook Hotel Trust
Valuation N/A
Financial Services
Price$19.12
Model IV—
P/IV—
Limited data — see page
PEBO
PEOPLES BANCORP INC
Fairly valued
Financial Services
Price$35.80
Model IV$39.15
P/IV0.89
Discount 9% Return to IV: +9.4%
PERI
Perion Network Ltd.
Deeply overvalued
Technology
Price$8.86
Model IV$1.93
P/IV4.47
Premium +358% Return to IV: -78.2%
Market implies +24.9%/yr vs model +4.9% · above model
PFIS
PEOPLES FINANCIAL SERVICES CORP.
Fairly valued
Financial Services
Price$67.25
Model IV$61.62
P/IV0.96
Premium +9% Return to IV: -8.4%
PFLT
PennantPark Floating Rate Capital Ltd.
Valuation N/A
Unknown
Price$6.68
Model IV—
P/IV—
Limited data — see page
PGC
PEAPACK GLADSTONE FINANCIAL CORP
Deeply overvalued
Financial Services
Price$43.37
Model IV$29.03
P/IV1.49
Premium +49% Return to IV: -33.1%
PGEN
PRECIGEN, INC.
Valuation N/A
Healthcare
Price$7.81
Model IV—
P/IV—
Market implies +111.8%/yr vs model +2.0% · above model
PGNY
Progyny, Inc.
Deeply overvalued
Healthcare
Price$27.93
Model IV$18.77
P/IV1.38
Premium +49% Return to IV: -32.8%
Market implies +15.9%/yr vs model +15.0% · in line
PGY
Pagaya Technologies Ltd.
Deeply undervalued
Financial Services
Price$18.22
Model IV$40.83
P/IV0.37
Discount 55% Return to IV: +124.1%
Market implies +4.3%/yr vs model +23.2% · below model
PHAR
Pharming Group N.V.
Fairly valued
Healthcare
Price$9.79
Model IV$11.23
P/IV0.86
Discount 13% Return to IV: +14.8%
Market implies +6.7%/yr vs model +12.2% · below model
PHAT
Phathom Pharmaceuticals, Inc.
Deeply overvalued
Healthcare
Price$7.25
Model IV$2.09
P/IV4.58
Premium +246% Return to IV: -71.1%
Market implies +18.2%/yr vs model +15.0% · above model
PHOE
Phoenix Asia Holdings Ltd
Valuation N/A
Industrials
Price$17.51
Model IV—
P/IV—
Market implies +28.0%/yr
PHR
Phreesia, Inc.
Deeply undervalued
Technology
Price$10.81
Model IV$24.77
P/IV0.39
Discount 56% Return to IV: +129.1%
Market implies -13.5%/yr vs model +22.5% · below model
PHVS
Pharvaris N.V.
Valuation N/A
Healthcare
Price$31.10
Model IV—
P/IV—
Limited data — see page
PICS
PicS N.V.
Valuation N/A
Financial Services
Price$13.60
Model IV—
P/IV—
Limited data — see page